Clarity for your next GLP-1 supply decision.
Research and practical tools for US weight-management and telehealth clinics. Compare GLP-1 supply routes, understand total costs and know what to check before choosing a supplier or dispensing partner.
Understand the arrangement.
Know what needs checking.

First, identify what
the quote actually covers.
Keep formulation, presentation, pack and payer attached to every comparison. Similar descriptions can conceal very different arrangements.
A prescription does not, by itself, establish permission to compound.
Record the preparation, destination and documented basis for review before discussing savings.
Screen a proposed arrangementIdentify the preparation
Exact formulation, product status and asserted pathway.
Attach the destination
Facility, operating model and destination-state evidence.
Name the open questions
Missing evidence stays visible. Assessment incomplete means incomplete.
Why 503A and 503B need different checks +
These are distinct federal frameworks with different conditions. Patient-specific dispensing, facility registration and adding an ingredient do not independently establish permission for a proposed preparation. Read the sourced comparison →
Compare arrangements.
Keep responsibilities visible.
Branded access, pharmacy dispensing and proposed compounding require different checks. Start with the same questions.
Responsibility map only. Programme access is not an assumed wholesale route; patient-specific dispensing is not a separate compounding permission.
Choose the right
level of support.
Find your approach · 2-minute guide 
A comparison you can take forward.
- 01Confirm the inputs
- 02Compare the particulars
- 03Export your working file
The quote is one line.
The cost is a schedule.
Compare ongoing economics under matched assumptions. Keep patient, insurer and clinic expenditure separate.
Illustrative USD inputs · 100 enrolled months · one monthly pack each · zero extra wastage packs. Costs incurred for all enrolled months.
Calculate your matched costsper successfully fulfilled
patient-month
An operational proxy, not a clinical outcome.
Modelled cost: $468.42 per fulfilled month.
Something useful
to take to the next meeting.
Preview the structure. Try it with your assumptions. Export a working file your procurement team can act on.
The arrangement, on one sheet.
Every output keeps the assumptions, source limits and unresolved questions alongside the result.
Open this working sheetExplore all ten toolsILLUSTRATIVE EXCERPT
Supply routes
Source / assumption / evidence boundary
Source / assumption / evidence boundary
Source / assumption / evidence boundary
Next owner: procurement lead · specialist review pending
What changed?
What needs another review?
Practical guidance organised around the decisions on your desk. Read the finding, affected arrangement and evidence boundary together.

What evidence should be in a GLP-1 supplier due-diligence file?
Build the file around the specific facility and proposed arrangement.
Read the briefingWhat is the difference between 503A and 503B GLP-1 compounding for clinics?
How should clinics compare GLP-1 pharmacy quotes?
How can a clinic switch GLP-1 pharmacy partners without disrupting treatment?
4 featured briefings shown. 4 briefings match your filter.
Before the contract,
name the unresolved
questions.
Turn the research into a clear brief: who owns the work, what needs specialist review and what to ask the supplier next.
Prepare your procurement briefPreview your brief before adding your work email.